Document is current
Any future updates will be listed below
-
Authors
Pan, Jason J.
Horwich, Brian H.
Chahine, Mohamad
Gutierrez, Julio A.
Saab, Sammy
- License Information
-
More Information
Article History
Received: 15 October 2025
Accepted: 14 May 2026
First Online: 17 June 2026
Declarations
:
: JJP, BHH, MC have no relevant financial disclosures to report. Author JAG is a shareholder of Novo Nordisk, shareholder of Viking, consultant and speaker for Madrigal, consultant and shareholder for Altimmune Inc, speaker for AbbVie, speaker for Gilead Sciences, and speaker for Ipsen. Author SS is a speaker for the following companies: AbbVie, Gilead Sciences, Novo Nordisk, Salix, Takeda, Mallinckrodt Pharmaceuticals, Madrigal, Ipsen, Eisai, Sequana. Author SS is a consultant for the following companies: Gilead Sciences, Mallinckrodt Pharmaceuticals, Madrigal, Ipsen, Sequana.
